Impact Factor
3.69
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.75
1,241 total citations
h5-index
39
h5 depth signal
Cited share
72.1%
245 of 340
Total citations
1,241
Citation footprint
Metric signal
3.46
External metric anchor
Self-citation
10.7%
133 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,123
China
240
Canada
165
Brazil
131
Australia
107
Citing Fields of Research
Endocrine Therapy
1,324
Reproductive Health
551
Human Reproduction
493
Obstetrics/Gynecology
224
Urology
160
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
6,102
Articles tracked across the journal lifetime
Indexed publication set
340
245 cited publications
Last 12 months
253
21.1 publications/month
Open access share
24.5%
62 OA publications in the last year
Leading citing country
United States
1,123 citing publications
Leading citing field
Endocrine Therapy
1,324 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v5n1,spring 1998-
v5n1,spring 1998-
Active Coverage
Research Focus & Classification
Indexed Subjects
Endocrine Therapy
Issuing & Sponsoring Bodies
Contributor
North American Menopause Society
Broad Categories
Gynecology
Endocrine Therapy
MeSH Descriptors
Menopause
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/gme.0000000000002827
Open DOI
The effectiveness of physical activity interventions on non-physiological symptoms of menopause: a systematic review and meta-analysis
Importance: Women in the menopause transition (MT) commonly experience mood disturbances, anxiety, cognitive complaints, and reduced quality of life (QoL). Yet access to pharmacological or psychological treatments may be limited or unsui...
02
DOI 10.1097/gme.0000000000002925
Open DOI
Trends of menopausal hormone therapy across Canadian provinces in 2018-2023
Objectives: Menopausal hormone therapy (MHT) is guideline-recommended as the first-line treatment for vasomotor symptoms in women without contraindications. Despite this, use of MHT remains low with persistent concerns about safety follo...
03
DOI 10.1097/gme.0000000000002924
Open DOI
Menopausal hormone therapy combined with antiresorptive therapy for skeletal outcomes in postmenopausal women: a systematic review and network meta-analysis of randomized controlled trials
Importance: Postmenopausal bone loss is a major contributor to osteoporosis, fracture-related morbidity, loss of independence, and mortality. Although systemic menopausal hormone therapy (MHT), antiresorptive therapy, and combination reg...
04
DOI 10.1097/gme.0000000000002895
Open DOI
Regular physical activity is associated with lower odds of bodily pain in midlife women
Objective: To evaluate the association between regular physical activity and bodily pain domain of the SF-36 in midlife women, considering pharmacological and physical factors. Methods: This cross-sectional study included 3,523 women age...
05
DOI 10.1097/gme.0000000000002909
Open DOI
Quantitative assessment of neurokinin receptor antagonists in menopausal hot flashes: a model-based meta-analysis
Importance: Neurokinin 3 receptor antagonists (NK3-RAs) represent a novel class of nonhormone agents for the treatment of hot flashes in women with menopause. Objective: This study aims to quantitatively evaluate treatment efficacy by de...
06
DOI 10.1097/gme.0000000000002907
Open DOI
Premature menopause and risk of type 2 diabetes among postmenopausal women: findings from the Women’s Health Initiative
Objective: The association between premature menopause (age below 40 y) and subsequent risk of type 2 diabetes (T2D) is not fully understood. Sex hormone fluctuation due to ovarian function, hormone therapy (HT), and menopause-related ch...
07
DOI 10.1097/gme.0000000000002922
Open DOI
Effects of adherence to a Mediterranean diet on body weight in postmenopausal women: a systematic review
Importance: The Mediterranean diet (MedDiet) is characterized by high consumption of whole grains, fruits, vegetables, olive oil, and fish, and adherence has been recognized as a strategy for improving metabolic health. The postmenopausa...
08
DOI 10.1097/gme.0000000000002893
Open DOI
Awareness and clinical impact of the revised FDA warning on menopausal hormone therapy among Latin American physicians. REDLINC XIV
Objective: To evaluate Latin American physicians’ awareness regarding the recent revised statement of the US Food and Drug Administration (FDA) “black box warning” on menopausal hormone therapy (MHT) and to analyze its self-reported impa...
09
DOI 10.1097/gme.0000000000002913
Open DOI
Reproductive history and age at natural menopause in US women: a cross-sectional analysis of National Health and Nutrition Examination Survey 1999 to March 2020
Objective: The associations of parity and gravidity with age at natural menopause (ANM) remain incompletely characterized. We examined parity‐ANM and gravidity‐ANM associations and explored non‐live-birth pregnancies descriptively in a n...
10
DOI 10.1097/gme.0000000000002888
Open DOI
Associations of psychosocial supports and stressors with cognition in midlife women
Objectives: Psychosocial supports and stressors can influence neurocognitive function, but associations are understudied among women in midlife. Methods: Among 492 parous women in the longitudinal Project Viva cohort, we surveyed several...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 25, no. 12 (2018).
Also issued online.